39 certified Labor Condition Applications on file with the U.S. Department of Labor, FY2021–FY2026.
Since September 2025, DOL's Project Firewall opens H-1B investigations without waiting for a complaint. These checkpoints come from Karyopharm Therapeutics Inc.'s own public LCA filings (FY2024–FY2026) — the same records an investigator pulls first.
Each worksite needs its own 10-business-day LCA notice and a PAF record of that posting; a move to a new area of intended employment needs a new LCA before the worker starts there.
Median offered wage is 1% above the DOL prevailing wage across 11 recent certified LCAs. Paying at the floor is lawful, but it invites the question of whether the wage level itself is right.
Withdrawn or denied LCAs are normal in isolation; a high share suggests workers were moved between filings and the paper trail needs checking.
Level I is the entry-level prevailing-wage tier and the band DOL's Project Firewall reviews first for misclassification (senior duties filed at an entry-level wage). The national share is 17%.
No additional recruitment or non-displacement attestations apply.
Public DOL disclosure data can lag actual filings by a quarter. Descriptive only — not legal advice.
Yes — Karyopharm Therapeutics Inc. sponsors H-1B workers, with 39 certified LCAs on file (FY2021–FY2026), including 4 in FY2026. The median certified salary is $132,657 (P25 $120,000, P75 $160,342). With a 33% transfer share, this employer actively accepts H-1B transfers. 100% of its certified filings meet or exceed the prevailing wage.
Karyopharm Therapeutics Inc. H-1B sponsorship at a glance, from public U.S. DOL LCA disclosure data (FY2021–FY2026).
Certified LCAs are a prerequisite to H-1B petitions, not visa approvals; one LCA can cover multiple workers. Descriptive only — not legal advice.
The shaded band is the middle half of certified salaries (P25–P75); the bar spans the lowest to highest certified salary.
Levels I–IV are DOL prevailing-wage experience tiers; 67% of filings are senior-level (III–IV).
| Fiscal year | Certified | Denied | Withdrawn | Total |
|---|---|---|---|---|
| FY2021 | 10 | 0 | 2 | 12 |
| FY2022 | 8 | 0 | 3 | 11 |
| FY2023 | 10 | 0 | 6 | 16 |
| FY2024 | 1 | 0 | 1 | 2 |
| FY2025 | 6 | 0 | 2 | 8 |
| FY2026 | 4 | 0 | 0 | 4 |
Case dispositions from the U.S. DOL OFLC disclosure files. Withdrawn are LCAs that were certified and later withdrawn by the employer; they still count toward Total.
| Job title | Salary | Level | Location | Filed | Status |
|---|---|---|---|---|---|
Associate Director, Regulatory Operations I-200-26079-719715 | $188,500/yr | III | Newton, MA | Mar 20, 2026 | Certified |
Senior Manager, Regulatory Operations I-200-26079-718687 | $190,215/yr | III | Newton, MA | Mar 20, 2026 | Certified |
Senior Manager, Regulatory Operations I-200-26079-719694 | $188,500/yr | III | Newton, MA | Mar 20, 2026 | Certified |
Sr Scientist, Analytical Chemistry I-200-25316-401122 | $153,480/yr | IV | Newton, MA | Nov 12, 2025 | Certified |
Senior Clinical Data Manager I-200-25260-315964 | $132,656/yr | IV | Farmington, AR | Sep 17, 2025 | Certified |
Manager, Regulatory Operations I-200-25190-161262 | $139,932/yr | IV | Morrisville, NC | Jul 09, 2025 | Certified |
Senior Statistical Programmer 1 I-200-25111-886404 | $123,965/yr | III | Newton, MA | Apr 21, 2025 | Certified |
Sr Clinical Data Manager I-200-25107-873684 | $132,717/yr | II | Haymarket, VA | Apr 16, 2025 | Certified |
GCP Documentation Specialist I-200-25105-866369 | $96,616/yr | II | Newton, MA | Apr 15, 2025 | Certified |
Senior Biostatistician I-200-25009-606996 | $187,044/yr | IV | Newton, MA | Jan 09, 2025 | Certified |
Senior Clinical Data Manager I-200-23338-541435 | $124,500/yr | III | Farmington, AR | Dec 04, 2023 | Certified |
Sr. Clinical Trial Manager I-200-23202-205948 | $160,000/yr | IV | Newton, MA | Jul 21, 2023 | Certified |
Manager, Regulatory Operations I-200-23104-934396 | $130,000/yr | IV | Des Plaines, IL | Apr 14, 2023 | Certified |
Associate Director, IST Operations I-200-23090-892502 | $124,747/yr | IV | Edgewater, NJ | Mar 31, 2023 | Certified |
Manager Regulatory Operations I-200-23089-890084 | $109,745/yr | IV | Newton, MA | Mar 30, 2023 | Certified |
Senior Manager, Regulatory Operations I-200-23089-889988 | $160,685/yr | III | Newton, MA | Mar 30, 2023 | Certified |
Senior Manager, Regulatory Operations I-200-23089-889620 | $170,000/yr | III | Newton, MA | Mar 30, 2023 | Certified |
Sr Scientist, Analytical Chemistry I-200-23089-889509 | $143,763/yr | IV | Newton, MA | Mar 30, 2023 | Certified |
Senior Clinical Data Manager I-200-23005-683715 | $120,000/yr | III | Apex, NC | Jan 05, 2023 | Certified |
Sr Clinical Data Manager I-200-22284-523514 | $120,000/yr | II | Centerville, VA | Oct 11, 2022 | Certified |
Associate Director/Director, Clinical Pharmacology and DMPK I-200-22194-349768 | $170,475/yr | IV | Merced, CA | Jul 13, 2022 | Certified |
Sr Scientist Bioanalytical I-200-22112-096993 | $145,000/yr | IV | Newton, MA | Apr 22, 2022 | Certified |
GCP Documentation Specialist I-200-22096-043612 | $86,781/yr | II | Newton, MA | Apr 06, 2022 | Certified |
Manager, Regulatory Affairs I-200-22049-913378 | $120,000/yr | II | Newton, MA | Feb 18, 2022 | Certified |
Senior Medical Director, Pharmacovigilance I-200-22033-872422 | $265,000/yr | IV | Newton, MA | Feb 02, 2022 | Certified |
Associate Director, XPOVIO U.S. Multiple Myeloma Marketing I-200-21351-773227 | $169,000/yr | III | Newton, MA | Dec 17, 2021 | Certified |
Senior Biostatistician I-200-21334-732915 | $149,968/yr | IV | Newton, MA | Nov 30, 2021 | Certified |
Clinical Data Manager I-200-21303-677822 | $100,942/yr | IV | Albuquerque, NM | Oct 30, 2021 | Certified |
Associate Director/Director, Clinical Pharmacology and DMPK I-200-21237-546000 | $170,000/yr | IV | Exton, PA | Aug 25, 2021 | Certified |
Clinical Research Scientist, Clinical Development I-200-21107-233973 | $100,000/yr | II | Newton, MA | Apr 17, 2021 | Certified |
Senior Medical Director, Pharmacovigilance I-200-21021-024993 | $265,000/yr | IV | Newton, MA | Jan 21, 2021 | Certified |
Senior Medical Director, Pharmacovigilance I-200-21021-024926 | $265,000/yr | IV | Newton, MA | Jan 21, 2021 | Withdrawn |
Scientist, Analytical Chemistry I-200-20335-931043 | $123,000/yr | II | Newton, MA | Nov 30, 2020 | Certified |
Clinical Data Manager I-200-20280-860150 | $100,942/yr | II | Newton, MA | Oct 06, 2020 | Certified |
Pharmacovigilance Scientist I-200-20073-405650 | $135,000/yr | IV | Newton, MA | Mar 13, 2020 | Certified, withdrawn |
Pharmacovigilance Specialist I-200-20051-339555 | $110,000/yr | III | Newton, MA | Feb 20, 2020 | Certified, withdrawn |
Pharmacovigilance Scientist I-200-20036-298432 | $140,000/yr | IV | Newton, MA | Feb 04, 2020 | Certified, withdrawn |
One row per LCA case (its latest version), from U.S. DOL OFLC disclosure data. Salaries are the offered wage, converted to a yearly figure. Certified LCAs are not visa approvals.
Worker positions by LCA filing purpose, summed across FY2021–FY2026 disclosure records.
Most active filing months: Mar and Apr — useful for timing transfer conversations.
Attestations from the employer's own LCA filings (Form ETA-9035), as disclosed by the U.S. DOL.
9 states · 11 cities
The same DOL data on this page is what every H-1B sponsor must track for each worker. ElevateStaffing.ai automates it end-to-end:
Get the private PAF / LCA gap check for your own filings — free, one business day — then let ElevateStaffing.ai keep every LCA, PAF, I-9 and I-983 deadline audit-ready.
Get my private gap check →